Series A Funding for Theolytics

 

Theobald Associates is pleased to announce the successful closing of a Series A Fundraising Extension for its client, Theolytics Limited. The transaction funds will be used for the advancement of its viral cancer therapies. Further details can be found at: https://www.theolytics.com/post/theolytics-expands-series-a-financing-and-welcomes-m-ventures-as-a-new-investor